Secondary Myelodysplastic Syndrome — Trials

Secondary Myelodysplastic Syndrome — Trials · CancerIndex

Clinical trials

Registered studies

33 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 4
Ph III recruiting: 0
Growth YoY: —
Industry share: 13%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03272633	Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies	terminated	Early Phase 1	2	Rutgers, The State University of New JerseyOTHER	1	Jun 26, 2023	clinicaltrials

Data updated 22 days agoSource updated Jun 26, 2023source: clinicaltrials